JenniferSassonMD

Internal Medicine • Charlottesville, VA

Infectious Disease

Assistant Professor, Department of Medicine, Division of Infectious Disease at the University of Virginia

Join to view full profile

Dr. Sasson is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Sasson's full profile

Already have an account?

Office
1215 Lee St # 800744
Charlottesville, VA 22908
Phone+1 434-924-1931

Fax+1 434-243-5770
Is this information wrong?

Education & Training

University of Virginia Medical CenterFellowship, Infectious Disease, 2020 - 2023
University of Virginia Medical CenterResidency, Internal Medicine, 2017 - 2020
SUNY Upstate Medical UniversityClass of 2017

Certifications & Licensure

VA State Medical License 2017 - 2024
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Infectious Disease

Publications & Presentations

PubMed

Pulmonary Function and Survival 1 Year After Dupilumab Treatment of Acute Moderate to Severe Coronavirus Disease 2019: A Follow-up Study From a Phase 2a Trial.
Ma, J., Haughey, H., Coleman, R., Nayak, U., Young, M., Allen, J., Hendrick, J., Kadl, A., Sturek, J., Jackson, P., Petri, W.> ;Open Forum Infectious Diseases. 2024 Feb 1
Pulmonary function and survival one year after dupilumab treatment of acute moderate to severe COVID-19: A follow up study from a Phase IIa trial.
Jennifer Hendrick, Jennie Z Ma, Heather M Haughey, Rachael Coleman, Uma Nayak, Alexandra Kadl, Jeffrey M Sturek, Patrick Jackson, Mary K Young, Judith E Allen, William...> ;Medrxiv. 2023 Sep 2
6 citations
The role of interleukin 13 and the type 2 immune pathway in COVID-19: A review.
Jennifer Sasson, G Brett Moreau, William A Petri Jr> ;Annals of Allergy, Asthma & Immunology. 2023 Jun 1
12 citations
Safety and Efficacy of Dupilumab for the Treatment of Hospitalized Patients With Moderate to Severe Coronavirus Disease 2019: A Phase 2a Trial.
Jennifer Sasson, Alexandra N Donlan, Jennie Z Ma, Heather M Haughey, Rachael Coleman, Uma Nayak, Amy J Mathers, Sylvain Laverdure, Robin Dewar, Patrick E H Jackson, Sc...> ;Open Forum Infectious Diseases. 2022 Aug 1
3 citations
Safety and Efficacy of Dupilumab for the Treatment of Hospitalized Patients with Moderate to Severe COVID 19: A Phase IIa Trial.
Jennifer Sasson, Alexandra N Donlan, Jennie Z Ma, Heather M Haughey, Rachael Coleman, Uma Nayak, Amy J Mathers, Sylvain Laverdure, Robin Dewar, Patrick E H Jackson, Sc...> ;Medrxiv. 2022 May 19
13 citations
Diverse Humoral Immune Responses in Younger and Older Adult COVID-19 Patients.
Jennifer M. Sasson, Joseph J. Campo, Rebecca M Carpenter, Mary K. Young, Arlo Randall, Krista Trappl-Kimmons, Amit Oberai, Christopher Hung, Joshua Edgar, Andy Teng, J...> ;Mbio. 2021 Jun 29
10 citations
IgG Antibodies against SARS-CoV-2 Correlate with Days from Symptom Onset, Viral Load and IL-10
Mary K. Young, Christine Kornmeier, Rebecca M Carpenter, Nick R Natale, Jennifer M. Sasson, Michael D. Solga, Amy J. Mathers, Melinda D. Poulter, Xiao Qiang, William A...> ;Medrxiv. 2020 Dec 7
Join now to see all

Press Mentions

Researchers Find Medicine for Asthma and Eczema Helps COVID PatientsAugust 11th, 2022
For Immunocompromised, Drug Could Offer Long-Lasting COVID-19 ProtectionNovember 12th, 2021